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Herpesvirustype2DNAwasdetectedbyPCRinthecerebrospinalﬂuidinayoungwomanpresentingwithheadache,stiﬀneckand
pleocytosis, and serological ﬁndings consistent with reactivation. Since she was exposed to ticks, Lyme disease and tick-borne en-
cephalitiswereexcluded.Furtherinvestigationinanongoingproject,usingPCRandsequencingoftheampliﬁedproducts,showed
thepresenceofRickettsiahelveticainthecerebrospinalﬂuid.ThebacteriawerealsoisolatedinVerocellculture,andmicroimmuno-
ﬂuorescence conﬁrmed the development of antibodies against Rickettsia spp. with predominance of IgM reactivity consistent with
recent infection. She was treated with antibiotics and improved rapidly. The patient could easily have been judged to have isolated
herpes meningitis. Because Sweden and other European countries are endemic areas for rickettsioses, the paper reaﬃrms the im-
portance of investigating for the presence of rickettsial infections in endemic areas in cases of meningitis of uncertain aetiology.
1.Introduction
Spotted fever rickettsiae (SFR) are small, aerobic, obligate
intracellular gram-negative organisms that primarily depend
on hematophagous arthropods as vectors and that have a
varyingabilitytocausediseaseinhumans[1,2].Ninespecies
of SFR have been described as emerging pathogens in
Europe, and in Sweden, both Rickettsia helvetica and Rick-
ettsia felis have been reported [3–5]. Ixodes ricinus ticks are
the main vector and reservoir for R. helvetica, which has an
estimated prevalence in the tick of between 1.7 and 20%
in European countries and is to date the only tick-trans-
mitted SFR reported from Sweden [1, 5–7]. Ticks from mi-
gratory birds have recently been shown to carry the SFR
agents, which probably contributes to the wide geographic
distribution of SFR and frequent reports of species found in
new locations [8].
SerosurveysofthepopulationinendemicareasinEurope
and Asia have identiﬁed signiﬁcant titres of antibodies in
a range between 2.6 and 12.8% [9–13]. Infection caused
by R. helvetica is a recently recognized spotted fever group
rickettsial disease. Most patients are diagnosed with a mild
febrileillness,sometimeswitharash.However,amoresevere
presentation as perimyocarditis has been reported, and in
one retrospective case, R. helvetica has been associated with
subacute meningitis [3, 9, 14]. Of the rickettsial diseases,
typhus, spotted fever, and Q-fever all may cause central
nervous system (CNS) infection, and of the SFR, R. rickettsii,
R. conorii,a n dR. japonica have a well-documented asso-
ciation with meningoencephalitis [15–17]. Also, R. felis,
whose main reservoir and vector is cat ﬂeas (Ctenocephalides
felis), has been shown to cause meningitis in two cases,
but has so far not been reported in any vector in Sweden
[4, 17].
Herpessimplexvirus2(HSV-2)iscloselyrelatedtoHSV-
1 and usually causes genital infections and persist latent
infection in neurons in the lumbosacral ganglia. One in four
adults is infected in Sweden. The virus is spread sexually, but
most of the infections are asymptomatic. In rare cases, how-
ever, the course of the infection is more complicated and
presents with meningitis and headache, sometimes with re-
current episodes (Mollaret’s meningitis) [18].2 Case Reports in Infectious Diseases
To raise awareness among clinicians of these infec-
tions, their similarities, and the possibility of coinfection,
we present the ﬁrst documented case of acute meningoen-
cephalitis, due to R. helvetica.
2. Case Presentation
A previously healthy 23-year-old woman, presenting with
headache (4-day duration), stiﬀ neck, and photophobia (1-
day duration), was hospitalized in July 2010 at the Depart-
ment of Infectious Diseases, Uppsala University Hospital,
Uppsala, Sweden. She had been living in the eastern archi-
pelago during the previous week. There were no proven tick
bites, but a small red papule was noted on her left thigh.
Clinicalexaminationrevealednosignsoflymphadenopa-
thyorrash,andtherewerenopulmonary,genital,orabdom-
inal symptoms. Body temperature was 38.5◦C at admission
but had previously been normal, probably because the pa-
tient had used antipyretic tablets.
Laboratory tests showed C-reactive protein at the upper
normal limit (11mg/L), normal peripheral leukocyte cell
count (7.2 × 109/L), and normal values for haemoglobin,
sodium, and potassium. The cerebrospinal ﬂuid (CSF)
revealed pleocytosis (868 × 106 cells/L, of which 820 × 106/L
were mononuclear cells), elevated albumin (2209mg/L),
and a slightly lowered blood glucose ratio (<0.5). She was
treated for meningitis of unknown aetiology and started
on cefotaxime, ampicillin, valacyclovir, and betamethasone
intravenously. She improved rapidly with treatment. Blood
and CSF bacterial cultures, as well as tests for Borrelia
and enteroviruses, were all negative. Tick-borne encephalitis
serology was consistent with previous vaccination. PCR for
HSV-2 in the CSF was positive. HSV-2 IgM in the serum was
weakly positive, and HSV-2 IgG was positive in both serum
and CSF with a ratio around 20. This was interpreted as
evidence of reactivation or an early phase of infection. By
coincidence, as a result of an ongoing project, the possibility
of rickettsial infection was considered and the investigation
revealedapositivedirectimmunoﬂuorescencetestoftheCSF
which was conﬁrmed by culture and qPCR of the CSF for
SFR. The antibiotic treatment was then changed to tablet
doxycycline (100mg pO b.i.d.) and continued for 2 weeks.
The characteristics and laboratory results are summa-
rized in Table 1.
Direct Immunoﬂuorescence on CSF. after centrifugation, a
drop of cerebrospinal ﬂuid, ﬁxed on a microscopic slide
and stained with rabbit anti-rickettsial hyper-immunoserum
and goat anti-rabbit immunoglobulin, was examined and
showedgreenﬂuorescentmicroorganismsofasizeandshape
corresponding to the Rickettsia. As mounting medium VEC-
TASHIELD with DAPI (4 , 6-diamidino-2-phenylindole)
(Vector Laboratories, Burlingame, USA) was used according
to the manufacturers instruction, showing the same ﬂuores-
cent organisms positive for bacterial DNA (Figures 1(a) and
1(b)).
Extraction and PCR. B a c t e r i a la n dv i r a lD N Aw a se x t r a c t e d
from a sample of CSF and later from the isolate obtained
Table 1: Summary of the disease history and laboratory ﬁndings.
R.h.: R. helvetica; doxy: doxycycline.
Characteristics
Sex, age in yrs F, 23
Month July
Fever, temp ◦C 38.5
Headache Yes
Stiﬀ neck Yes
Photophobia Yes
Treatment doxy
Outcome Cured
Lab results
C-reactive prot, mg/L 11
WBC count, g/L 7.2
CSF results
CSF cells (×106/L) total 868
Mono 820
Proteins (mg/L) 2209
CSF/blood glucose ratio 0.46
Serology
Acut phase/s
Ric-MIF IgG <32
Ric-MIF IgM 2048
CSF Ric-MIF IgG <32
Ric-MIF IgM <1/16
Convalescent phase/s
Ric-MIF IgG 64
Ric-MIF IgM 1024
Borrelia (IU/mL) serum Neg
(Index) CSF Neg
Isolation R.h
from Vero cell culture, using the NucliSENS easyMAG auto-
matedextractionplatform(bioM´ erieux,Durham,NC,USA)
according to the manufacturer’s instructions. The spotted
fever group of Rickettsia was assayed using a genus-speciﬁc
real-time PCR with probe and primers targeting the gltA
gene, as previously described [19]. The real-time PCR assays
for SFR and HSV were performed in a Rotor-Gene 3000
(Corbett Research, Sydney, Australia) using LC Taqman
Master kit (Roche, France) and were positive for both HSV-
2 and SFR. Reagent controls, containing no DNA, showed
no ampliﬁcation. The Ct values for SFR were between 34.86
and 37.79, indicating less than ten copies per reaction. This
corresponds with the detection limit by direct microscopy
where it is possible to detect 104 bacteria/mL.
The SFR positive samples were further analysed using
nested PCR assays that amplify the 17-kDa, ompBa n dgltA
genes, as previously described [20–22]. Conventional and
nested PCR were performed in a DNA thermal cycler
(Gene Amp PCR System 9700, PE Applied BioSystems,
USA), and expected fragment sizes were conﬁrmed using
gel electrophoresis (1% agarose, 0.01% ethidium bromide).Case Reports in Infectious Diseases 3
(a) (b)
Figure 1: Riskettsial organisms in recently drained CSF; (a) stained with anti-rickettsial antiserum and Alexa Fluor 488 goat anti-rabbit
immunoglobulin; (b) the same ﬁeld of view shows the organisms DNA stained with DAPI in the same location.
Conﬁrmation of fragment size was based on a standard DNA
molecularweightmarker(Fermentas,Helsingborg,Sweden).
As a negative control, sterile water was included in each
ampliﬁcation trial. Puriﬁed DNA of R. helvetica originally
isolated from an I. ricinus tick was used in these assays as the
positive control [7]. Direct cycle sequencing analysis of both
strands of the amplicons was performed using an automatic
ABI 3130 Genetic Analyzer (Applied Biosystems, Tokyo,
Japan). For species identiﬁcation, pair-wise similarities to
and diﬀerences from other rickettsiae in the spotted fever
group were examined using Blast analysis. Multiple sequence
alignments were conducted using BioEdit version 7.0.9 and
ClustalW. The obtained sequences in nested and conven-
tional PCR of partial regions of the 17kDa, ompB, and
gltA genes were 169bp (17kDa), 222bp (ompB), and 716bp
(gltA), respectively. Analyses of these amplicons shared
99-100% similarity with the corresponding gene sequences
of R. helvetica (GenBank accession numbers GU827073
(17kDa), AF123725 (ompB), and U59723(gltA)), with sig-
niﬁcant nucleotide diﬀerences from the other rickettsiae of
the spotted fever group.
RickettsialCulture. 100μLofCSFwasculturedineachoftwo
25cm2 ﬂasks onto conﬂuent monolayers of Vero cells. After
inoculation,thecellculturewasincubatedinEagle’sminimal
essential medium, containing 10% fetal calf serum and 1%
L-glutamine in a humid chamber in 5% CO2,a t3 2 ◦C. All
reagents and cell lines were checked weekly for rickettsial
growth and to exclude other bacterial contamination. Detec-
tion of rickettsial growth in the cell culture was monitored
using a direct immunoﬂuorescence assay of cells collected
after centrifuging the medium and attached to a microscope
slide. The preparation was stained with rabbit anti-rickettsial
hyperimmune serum and goat anti-rabbit IgG (H+L-chain)
immunoglobulin (Alexa Fluor 488) (H+L-chain) conjugate
(Invitrogen, Carlsbad, CA, USA) as secondary antibody. As
mounting medium VECTASHIELD with DAPI (Vector
Laboratories, Burlingame, USA) was used. After 3 weeks,
intracellularbacteriawereobservedinthecellsandrickettsial
DNA was veriﬁed by real-time PCR [19, 23].
Serology. HSV serology was performed in a Behring ELISA
processor III and 2000, respectively, according to the manu-
facturer’s instructions (Siemens, Diagnostic Products, Mar-
burg, Germany). HSV IgG (AE/mL) was 67 (positive) in CSF
and 1900 (positive) in serum. HSV IgM (OD) was not de-
tected in CSF and was 0.37 (weakly positive) in serum.
Immunoﬂourescentdetection(IFA)ofantibodiestoR.hel-
vetica in inoculated Vero cells. An aliquot of infected Vero
cell medium was supplemented with 10% yolk sac solution,
applied to microscope slide wells, dried, ﬁxed in acetone,
and incubated with serial dilutions of serum as previously
described [13]. As positive controls, a serum sample from
a patient with proven infection with Rickettsia conorii with
end-point IgG titres of 1:160, provided by the Swedish
Institute for Infectious Disease Control, and serum from
another patient with proven end-point IgG titres of 1:80
to R. helvetica were used. IgG and IgM antibodies were de-
tected using ﬂuorescein isothiocyanate-conjugated (FITC)
γ- and Mu-chain, respectively, speciﬁc polyclonal rabbit
anti-human IgG and IgM (ref.: F0202 and F0203; Dako,
Denmark). The IgM antibodies were examined after a pre-
treatment procedure with rheumatoid factor adsorbent (Im-
munkemi, Stockholm, Sweden) to remove complex bound
IgG antibodies. The IFA results are summarized in Table 1.
Predominant IgM reactivity to R. helvetica antigen and the
spotted fever group antigen was demonstrated in the acute
and convalescent phase sera. All negative controls were neg-
ative.
3. Discussion
The patient in this paper presented with symptoms of in-
creasing headache, neck stiﬀness, and fever after travelling
to the eastern archipelago of Sweden in the previous week.
Laboratory investigations showed a CSF pleocytosis, with
mononuclear predominance, a positive PCR test for HSV-2,
and HSV-2 serology indicating reactivation or early infec-
tion,resultinginadiagnosisofHSV-2meningitisandappro-
priate treatment. There were no classic tick bite marks or
a rash suggestive of rickettsial infection. Due to possible tick
exposure, and as a result of an ongoing Rickettsia project,4 Case Reports in Infectious Diseases
this patient was also included for investigation, which veri-
ﬁed the presence of R. helvetica in the CSF.
All the available diagnostic methods conﬁrmed a rick-
ettsial infection. Direct immunoﬂuorescence was a useful
tool in this case, due to the white blood cell elevation in the
CSF.Aswithothersimilarassays,ifthebacterialloadislowin
the CSF, the result may be negative (Figures 1(a) and 1(b)).
Furthermore, it requires technical expertise for reliable inter-
pretation.
Real-time PCR analysis of CSF provides the ability to
detect and diagnose early stages of rickettsial infections in
CNSbutaconventionalPCRishelpfultofurtheramplifyand
sequence the product for species identiﬁcation. In Sweden,
another spotted fever Rickettsia, R. felis, has also been shown
to cause meningitis recently. Distinguishing between these
two rickettsiae requires primer design encompassing a se-
quence suﬃcient for species diﬀerentiation [4].
Serological testing conﬁrmed the presence of signiﬁcant
titres of anti-rickettsial antibodies, predominantly IgM with
ahighertitreintheacute-phaseserumanddecreasingduring
convalescence. The development of an IgG titre was more
moderate, but it is reported that, in primary infections, in-
dividuals who have received antibiotic therapy initiated dur-
ing the ﬁrst week after disease onset showed strong IgM
responses without pronounced increases in IgG [24]. The
present ﬁndings demonstrate the importance of including
an IgM assay to obtain a reliable serological assessment and
better chance of early diagnosis.
We also isolated the rickettsial organism. In this case, the
conditions were optimal, because the delay between the time
ofsamplecollectionandinoculationontoshellvialswasonly
a matter of hours. Previous studies have shown that all cul-
tures of samples inoculated later than the day of sampling
andheldat4 ◦C or room temperature were negative [25].Iso-
lationthereforerequiresaccesstospecializedlaboratoryfacil-
ities within a reasonable distance.
For patients without rash or eschar, rickettsial diagnosis
isnoteasyandcannotbedeﬁnitivelyestablishedonepidemi-
ological,clinical,andstandardlaboratorycriteria.Adiagnos-
tic score to help the physician assess the diagnosis of SFR has
been previously described for Mediterranean spotted fever,
African tick bite fever, and lymphangitis-associated rick-
ettsiosis, but not for other less established rickettsial diseases
[26]. The diagnosis is established when laboratory ﬁndings
and epidemiological, clinical, bacteriological, and serological
criteria give a score equal to 25 or higher. In this case, using
the same criteria, isolation of the bacterium and the serolog-
ical ﬁndings provided a score well above 25. The utility of the
proposed criteria should be studied further for other species
of rickettsial diseases.
The standard treatment regimen for SFR consists of
200mg doxycycline (orally or intravenously), daily for 7–14
daysdependingontheclinicalcourse[27].Mostpatientswill
improve within the ﬁrst 24h after treatment begins, which
has led to the proposal of shorter regimens, but treatment
should at least be continued until the patient is afebrile for
24h. Obviously the patient was also infected with HSV-2.
She had no previous history of recurrent episodes of severe
headache, and the serological ﬁndings were suggestive of
reactivated HSV-2 infection, which was probably asymp-
tomatic in her case. It is possible that the rickettsial infection
reactivated her HSV-2 infection but the opposite is conceiv-
able as well as simultaneous infection by both agents at the
same time. Similar co-infection with R. japonica and EBV,
another latent virus, has been reported in a case with he-
patic failure [28]. There are similarities between the classic
symptomsofMollaret’smeningitisandarickettsialinfection,
suggesting that as long as the cause of Mollaret’s meningitis
is unknown, it might be of interest to investigate for SFR in
cases who may have been exposed to Rickettsia.
Early diagnosis of rickettsial infection is important, and
thoughSweden,likeotherEuropeancountries,isanendemic
area for R. helvetica, it is of importance that clinicians rou-
tinely consider rickettsial infections, besides other agents, in
patients with fever or meningitis residing in or travelling
to endemic areas. Since rickettsial infections are eminently
treatable, the availability of appropriate and timely diagnos-
tics is essential to optimize the clinical outcome of those
aﬀected.
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